The first and only study to look at isolate HIV-neutralizing antibodies from infants has found that novel antibodies that could protect against many variants of HIV can be produced relatively quickly after infection compared to adults. This suggests that various aspects of HIV-vaccine development, from design to administration, could be improved by mimicking infection and immune response in infants.
Residents on the South Side say cancer, violence prevention and sexually transmitted infections are among their top health concerns, according to a survey of 12 ZIP codes conducted by the University of Chicago Medicine. The 2016 Community Health Needs Assessment, published online in mid-June, also identifies diabetes among adults, pediatric asthma and pediatric obesity as other critical health issues faced by South Siders.
In an analysis recently published in BMJ, which coincided with the UN High Level Meeting on HIV in New York, Boston Medical Center clinician researchers assessed current global evidence and found that mandatory treatment for people with substance use disorders is not effective in reducing their drug use.
Loyola University Chicago scientists have solved a mystery that has long baffled HIV researchers: How does HIV manage to enter the nucleus of immune system cells? The discovery, reported in the journal PLOS Pathogens, could lead to effective new drugs to treat HIV/AIDS.
More gay and bisexual men than ever are getting tested for HIV, according to new data from the National Gay Men's Sex Survey. The survey is the largest of its kind in the UK and sheds light on the sexual health of men who have sex with men.
A Johns Hopkins University School of Medicine study of insurance coverage of more than 28,000 people with HIV concludes that a decades-old program that offers free medical care remains a critical necessity despite the availability of coverage under the Affordable Care Act.
University of Chicago scientists and their colleagues have developed an innovative computer model of HIV that gives real insight into how a virus 'matures' and becomes infective.
The first days after HIV infection are very important because sexual partners are exposed to extremely high risks of infection due to the subsequent high viral load in the infected person. Additionally, this period of time determines the further course of HIV infection. DZIF scientists from the Medical Center of the University of Munich and DZIF African partner institutions in Tanzania participated in a prospective, multinational study which investigated virological and immunological changes due to HIV.
Findings published last week in the journal PLOS ONE confirm that researchers from the Oak Crest Institute of Science have demonstrated for the first time that two powerful antiretroviral drugs can provide complete protection against HIV when delivered topically by a sustained release intravaginal ring (IVR) device. The combination of tenofovir disoproxil fumarate and emtricitabine delivered at independently controlled rates via the pod-IVR was successful at preventing SHIV162p3 infection for over four months.
According to researchers, people with HIV-associated lymphoma who receive autologous stem cell transplant have similar survival rates and are no more at risk of serious complications compared to those without HIV receiving this therapy.